로딩 중…
지수 로딩 중…
Green Cross Medical Science Corporation
142280· KOSDAQ· Health Care· Health Care Equipment & Services
₩3,300-0.15%
2026-09-18
Financials
Valuation Metrics
Green Cross Medical Science Corporation's Market Cap is ₩791B. At end of 2025 it was ₩960B. Ranked #1433 of 2,421 in KR market (top 59%), #820 of 1,640 on KOSDAQ (top 50%), #53 of 96 in Health Care Equipment & Services (top 55%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 79.08B KRW | KR#1,433/2,421 Sec#53/96 |
| Revenue | 102.16B KRW | KR#1,403/2,421 Sec#35/96 |
| Net Income | -2.03B KRW | KR—/2,421 Sec—/96 |
| Total Assets | 90.51B KRW | KR#1,857/2,421 Sec#56/96 |
| Net Assets | 46.37B KRW | KR#1,957/2,421 Sec#62/96 |
| Employees | 133 | KR#1,415/2,421 Sec#47/96 |
| Value | ||
| P/B | 1.71x | KR#1,841/2,421 Sec#62/96 |
| P/S | 0.77x | KR#1,217/2,421 Sec#18/96 |
| EV/EBITDA | 37.70x | KR#1,273/2,421 Sec#42/96 |
| FCF Yield | 3.13% | KR#978/2,421 Sec#29/96 |
| Profitability | ||
| ROE | -4.38% | KR#1,777/2,421 Sec#60/96 |
| ROA | -2.24% | KR#1,772/2,421 Sec#59/96 |
| Op. Margin | 2.32% | KR#1,340/2,421 Sec#48/96 |
| Revenue Growth | -8.46% | KR#1,887/2,421 Sec#81/96 |
| Earnings Growth | -168.46% | KR#1,222/2,421 Sec#43/96 |
| Financial Health | ||
| Debt Ratio | 95.21% | KR#1,511/2,421 Sec#76/96 |
| Total Debt | 10.58B KRW | KR#1,607/2,421 Sec#51/96 |
| FCF | 2.48B KRW | KR#1,052/2,421 Sec#30/96 |
| Cash | 372.6M KRW | KR#2,370/2,421 Sec#95/96 |
| Current Ratio | 1.47x | KR#1,232/2,421 Sec#67/96 |
| Net Debt/EBITDA | 4.31x | KR#987/2,421 Sec#38/96 |
| Dividend | ||
| Div. Growth | 0.00% | KR—/2,421 Sec—/96 |
| Performance | ||
| 1Y Return | -20.39% | KR#1,277/2,421 Sec#28/96 |
| 1M Return | 27.41% | KR#154/2,421 Sec#6/96 |
| From 52W High | -50.45% | KR#1,417/2,421 Sec#44/96 |
| 1Y MDD | -61.56% | KR#1,565/2,421 Sec#54/96 |
| Trading | ||
| Volume | 512,431 shares | KR#228/2,421 Sec#6/96 |
| Trading Value | 1.69B KRW | KR#593/2,421 Sec#15/96 |
| Foreign Own. | 1.02% | KR#2,031/2,421 Sec#79/96 |
| Per Share | ||
| EPS | -85 KRW | KR—/2,421 Sec—/96 |
| BPS | 1,935 KRW | KR#2,082/2,421 Sec#70/96 |
Company Info
동사는 2003년 체외진단용의약품 제조판매를 목적으로 설립되었고, 2015년 녹십자메디스를 인수하며 자회사로 편입하였음. 2019년 충북 음성에 국내 최대 혈액투석액 생산시설을 갖추었고, 다양한 진단시약 및 의료기기, 혈액투석액 사업을 영위하고 있음. 유전체분석과 AI를 활용한 다중 진단 플랫폼으로의 전환과 첨단 POCT 진단시스템 개발을 바탕으로 혁신을 추구하고 있음. 녹십자엠에스는 2003년에 설립되었으며 경기도 용인시에 본사를 두고 있습니다.